Prestige Consumer Healthcare PBH Cash Flow Statement
| TTM Q4 '26 | TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | ||
|---|---|---|---|---|---|---|
| $190.3M-11.3% | $186.5M-12.8% | $200.84M-2.5% | $213M+3.8% | $214.61M+2.5% | ||
| $31.27M+3.6% | $30.17M-1.9% | $29.45M-6.6% | $29.72M-4.9% | $30.17M-1.6% | ||
| $10.84M-2.9% | $10.92M-10.1% | $11.05M-5.9% | $11.41M-14.1% | $11.16M-20.4% | ||
| $257.63M+2.4% | $276.63M+7.8% | $263.44M+0.2% | $275.75M+7.9% | $251.52M+1.0% | ||
| $11.18M+35.9% | $9.45M+19.8% | $7.99M-4.0% | $7.91M-14.3% | $8.22M-13.9% | ||
| $123.74M+1,400% | $94.86M+975% | $65.99M+602% | $37.12M+272% | $8.25M-21.9% | ||
| -$136.84M-684% | -$136.91M-372% | -$18.16M+23.2% | -$17.26M+29.7% | -$17.45M+13.2% | ||
| $156.28M+203% | $166.91M— | $123.49M— | $60.31M— | $51.51M— | ||
| $40M— | $30M— | —— | —— | —— | ||
| $40M— | -$135M-800% | -$75M-650% | -$35M-800% | $0— | ||
| -$156.06M+14.3% | -$129.45M+45.8% | -$176.58M+29.4% | -$152.84M+39.4% | -$182.08M+24.5% | ||
| —— | —— | —— | $105.91M+621% | $52.08M+533% | ||
| $246.45M+1.3% | $267.19M+7.4% | $255.45M+0.3% | $267.84M+8.7% | $243.29M+1.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Prestige Consumer Healthcare's cash flow data come from?
- Every line is extracted from Prestige Consumer Healthcare's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.